Bandhan BSE Healthcare Index Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 17-04-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 20.01 22.27 25.41 1.94 4,914.64
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 20.37 22.50 25.09 1.94 3,610.51
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 15.25 18.70 24.79 1.93 3,018.76
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 17.45 16.82 23.02 1.96 2,667.40
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 15.91 18.52 22.13 2.17 1,183.65

Fund Holdings as on 31-March-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Max Healthcare Institute Limited

  • Divi's Laboratories Limited

  • Dr. Reddy's Laboratories Limited

  • Apollo Hospitals Enterprise Limited

  • Lupin Limited

  • Fortis Healthcare Limited

  • Torrent Pharmaceuticals Limited

  • Aurobindo Pharma Limited

  • Mankind Pharma Limited

  • Alkem Laboratories Limited

  • Laurus Labs Limited

  • Glenmark Pharmaceuticals Limited

  • Zydus Lifesciences Limited

  • IPCA Laboratories Limited

  • Abbott India Limited

  • Krishna Institute Of Medical Sciences Limited

  • Biocon Limited

  • Suven Pharmaceuticals Limited

  • Syngene International Limited

  • Piramal Pharma Limited

  • Gland Pharma Limited

  • Wockhardt Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Narayana Hrudayalaya Limited

  • Ajanta Pharma Limited

  • Aster DM Healthcare Limited

  • Neuland Laboratories Limited

  • Global Health Limited

  • Concord Biotech Limited

  • Dr. Lal Path Labs Limited

  • Poly Medicure Limited

  • Natco Pharma Limited

  • Rainbow Childrens Medicare Limited

  • Granules India Limited

  • Jubilant Pharmova Limited

  • Pfizer Limited

  • Ami Organics Limited

  • Eris Lifesciences Limited

  • Jupiter Life Line Hospitals Limited

  • Triparty Repo TRP_020425

  • AstraZeneca Pharma India Limited

  • Sanofi India Limited

  • Alembic Pharmaceuticals Limited

  • Vijaya Diagnostic Centre Limited

  • Marksans Pharma Limited

  • Strides Pharma Science Limited

  • Indegene Limited

  • Sanofi Consumer Healthcare India Limited

  • Caplin Point Laboratories Limited

  • Metropolis Healthcare Limited

  • Procter & Gamble Health Limited

  • Aarti Pharmalabs Limited

  • Sai Life Sciences Limited

  • Shilpa Medicare Limited

  • Alivus Life Sciences Limited

  • Kovai Medical Center and Hospital Limited

  • Healthcare Global Enterprises Limited

  • Blue Jet Healthcare Ltd

  • Emcure Pharmaceuticals Limited

  • FDC Limited

  • Supriya Lifescience Limited

  • Indraprastha Medical Corporation Limited

  • Morepen Laboratories Limited

  • Yatharth Hospital And Trauma Care Services Limited

  • Solara Active Pharma Sciences Limited

  • Sequent Scientific Limited

  • Hikal Limited

  • Sun Pharma Advanced Research Company Limited

  • Krsnaa Diagnostics Limited

  • Unichem Laboratories Limited

  • Dishman Carbogen Amcis Limited

  • Innova Captab Limited

  • Advanced Enzyme Technologies Limited

  • Akums Drugs and Pharmaceuticals Limited

  • Orchid Pharma Limited

  • Aarti Drugs Limited

  • Thyrocare Technologies Limited

  • RPG Life Sciences Limited

  • Gufic Biosciences Limited

  • Gujarat Themis Biosyn Limited

  • Indoco Remedies Limited

  • Windlas Biotech Limited

  • Artemis Medicare Services Limited

  • Bliss GVS Pharma Limited

  • Syncom Formulations India Limited

  • Vimta Labs Limited

  • Suven Life Sciences Limited

  • IOL Chemicals and Pharmaceuticals Limited

  • Sigachi Industries Limited

  • SMS Pharmaceuticals Limited

  • Shalby Limited

  • Lincoln Pharmaceuticals Limited

  • Novartis India Limited

  • Hester Biosciences Limited

  • Kopran Limited

  • Tarsons Products Limited

  • Senores Pharmaceuticals Limited

  • Themis Medicare Limited

  • GPT Healthcare Limited

  • Suraksha Diagnostic Limited

  • KMC Speciality Hospitals (India) Limited

  • Sastasundar Ventures Limited

  • NGL Fine Chem Limited

  • Cash Margin - CCIL

  • Net Current Assets

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

  • Chemicals

  • Plastic Products

  • Trading

  • Finance - NBFC

View More

About Bandhan BSE Healthcare Index Fund

Scheme Analysis

Bandhan BSE Healthcare Index Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Bandhan Mutual Fund. It was launched on 06-Sep-2024 and currently has an AUM of ₹17.34 crore. Bandhan BSE Healthcare Index Fund is benchmarked against BSE Health Care - TRI as primary index.

The NAV of Bandhan BSE Healthcare Index Fund ended up ₹0.09(0.92%)yesterday to ₹9.5477.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Bandhan BSE Healthcare Index Fund is managed by Abhishek Jain .

Fund House Contact

6th Floor, One World Centre, 841, Jupiter Mills Compound, Senapati Bapat Marg, Elphinstone Road (West), Mumbai - 400 013

022-66289999
022-24215052